To diet or not to diet in neonatal diabetes responding to sulfonylurea treatment
-
Sorin Ioacara
,
Alexandra Barosan
Abstract
Background
Neonatal diabetes mellitus (NDM) is defined as a monogenic form of diabetes that occurs in the first 6 months of life. As information on diet in NDM patients successfully treated with sulfonylurea is not yet available, we aimed to investigate the hypothesis that a carb-restricted diet is not needed in such cases.
Case presentation
In this case report, we present a successful implementation of a completely liberalized diet in a young patient with NDM, developmental delay and epilepsy (DEND syndrome), who was also switched to sulfonylurea treatment. The excellent metabolic control during follow-up despite completely ignoring any diet suggests that at least in some patients this approach might work.
Conclusions
If our proposed hypothesis is also confirmed by other reports, it might add significantly to the quality of life of these patients and broaden the knowledge in this medical field.
Acknowledgments
We thank Prof. Andrew Hattersley and Prof. Sian Ellard for their help with genetic testing.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Roopa KS, Pihoker C, Dolan LM, Standiford D, Badaru A, et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes 2013;14:174–80.Suche in Google Scholar
2. Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007;92:1276–82.10.1210/jc.2006-2490Suche in Google Scholar
3. Iafusco D, Massa O, Pasquino P, Colombo C, Iughetti L, et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 2012;49:405–8.10.1007/s00592-011-0331-8Suche in Google Scholar
4. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006;49:1190–7.10.1007/s00125-006-0246-zSuche in Google Scholar
5. Shimomura K, Hörster F, de Wet H, Flanagan SE, Ellard S, et al. A novel mutation causing DEND Syndrome. A treatable channelopathy of pancreas and brain. Neurology 2007;69:1342–9.10.1212/01.wnl.0000268488.51776.53Suche in Google Scholar
6. Zhou M, Tanaka O, Suzuki M, Sekiguchi M, Takata K, et al. Localization of pore-forming subunit of the ATP-sensitive K+-channel, Kir6.2, in rat brain neurons and glial cells. Brain Res Mol Brain Res 2002;101:23–32.10.1016/S0169-328X(02)00137-7Suche in Google Scholar
7. Quan Y, Barszczyk A, Feng Z, Sun HS. Current understanding of KATP channels in neonatal diseases: focus on insulin secretion disorders. Acta Pharmacol Sin 2011;32:765–80.10.1038/aps.2011.57Suche in Google Scholar PubMed PubMed Central
8. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005;54:2503–13.10.2337/diabetes.54.9.2503Suche in Google Scholar PubMed
9. Ashcroft FM. New uses for old drugs: neonatal diabetes and sulphonylureas. Cell Metab 2010;11:179–81.10.1016/j.cmet.2010.02.004Suche in Google Scholar PubMed
10. Naylor RN, Greeley SA, Bell GI, Philipson LH. Genetics and pathophysiology of neonatal diabetes mellitus. J Diabetes Investig 2011;2:158–69.10.1111/j.2040-1124.2011.00106.xSuche in Google Scholar PubMed PubMed Central
11. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467–77.10.1056/NEJMoa061759Suche in Google Scholar PubMed
12. Carmody D, Bell CD, Hwang JL, Dickens JT, Sima DI, et al. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab 2014;99:E2709–14.10.1210/jc.2014-2494Suche in Google Scholar PubMed PubMed Central
13. Babiker T, Shepherd MH, Hattersley AT. Continue with long term sulfonylureas in patients with mutations in the KCNJ11 gene when there is evidence of response even if insulin treatment is still required. Diabetes Res Clin Pract 2013;100:e63.10.1016/j.diabres.2013.03.029Suche in Google Scholar PubMed
14. Ioacara S, Flanagan S, Fröhlich-Reiterer E, Goland R, Simona F. First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment. J Diabetes Investig 2017;8:716–9.10.1111/jdi.12620Suche in Google Scholar PubMed PubMed Central
15. Babiker T, Vedovato N, Patel K, Thomas N, Finn R, et al. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia 2016;59:1162–6.10.1007/s00125-016-3921-8Suche in Google Scholar PubMed PubMed Central
16. Steinert RE, Beglinger C, Langhans W. Intestinal GLP-1 and satiation: from man to rodents and back. Int J Obes 2016;40:198–205.10.1038/ijo.2015.172Suche in Google Scholar PubMed
17. Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanné-Chantelot C, Nivot S, et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 2006;14:824–30.10.1038/sj.ejhg.5201629Suche in Google Scholar PubMed
18. Mlynarski W, Tarasov AI, Gach A, Girard CA, Pietrzak I, et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol 2007;3:640–5.10.1038/ncpneuro0640Suche in Google Scholar PubMed
19. Fendler W, Pietrzak I, Brereton MF, Lahmann C, Gadzicki M, et al. Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion. Diabetes Care 2013;36:2311–6.10.2337/dc12-2166Suche in Google Scholar PubMed PubMed Central
©2018 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Intracranial pathologies associated with central diabetes insipidus in infants
- Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls
- Evaluation of anthropometric parameters of central obesity in Pakistani children aged 5–12 years, using receiver operating characteristic (ROC) analysis
- A lower energetic, protein and uncooked cornstarch intake is associated with a more severe outcome in glycogen storage disease type III: an observational study of 50 patients
- Untreated congenital hypothyroidism due to loss to follow-up: developing preventive strategies through quality improvement
- The effect of 17 years of increased salt iodization on the prevalence and nature of goiter in Croatian schoolchildren
- Is there an association between thyrotropin levels within the normal range and birth growth parameters in full-term newborns?
- Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature
- Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy
- A personal series of 100 children operated for Cushing’s disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations
- 12-Week aerobic exercise and nutritional program minimized the presence of the 64Arg allele on insulin resistance
- Letter to the Editor
- Successful treatment of life-threatening severe metabolic acidosis by continuous veno-venous hemodialysis in a child with diabetic ketoacidosis
- Case Reports
- Two siblings with metachromatic leukodystrophy caused by a novel identified homozygous mutation in the ARSA gene
- To diet or not to diet in neonatal diabetes responding to sulfonylurea treatment
- Van Wyk-Grumbach syndrome with hemangioma in an infant
- Maternal iodine excess: an uncommon cause of acquired neonatal hypothyroidism
Artikel in diesem Heft
- Frontmatter
- Original Articles
- Intracranial pathologies associated with central diabetes insipidus in infants
- Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls
- Evaluation of anthropometric parameters of central obesity in Pakistani children aged 5–12 years, using receiver operating characteristic (ROC) analysis
- A lower energetic, protein and uncooked cornstarch intake is associated with a more severe outcome in glycogen storage disease type III: an observational study of 50 patients
- Untreated congenital hypothyroidism due to loss to follow-up: developing preventive strategies through quality improvement
- The effect of 17 years of increased salt iodization on the prevalence and nature of goiter in Croatian schoolchildren
- Is there an association between thyrotropin levels within the normal range and birth growth parameters in full-term newborns?
- Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature
- Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy
- A personal series of 100 children operated for Cushing’s disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations
- 12-Week aerobic exercise and nutritional program minimized the presence of the 64Arg allele on insulin resistance
- Letter to the Editor
- Successful treatment of life-threatening severe metabolic acidosis by continuous veno-venous hemodialysis in a child with diabetic ketoacidosis
- Case Reports
- Two siblings with metachromatic leukodystrophy caused by a novel identified homozygous mutation in the ARSA gene
- To diet or not to diet in neonatal diabetes responding to sulfonylurea treatment
- Van Wyk-Grumbach syndrome with hemangioma in an infant
- Maternal iodine excess: an uncommon cause of acquired neonatal hypothyroidism
